Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barragan

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Rotablator and endoprosthesis on the left main coronary trunk]A F Chaix, P Barragan, M Silvestri, et al.
Journal of the American College of Cardiology|May 12, 2000
Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective proceduresM Silvestri, P Barragan, J Sainsous, et al.
Catheterization and Cardiovascular Diagnosis|December 31, 1997
Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patientsP Barragan, J Sainsous, M Silvestri, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1994
[Pilot study of the efficacy of ticlopidine in early patency of coronary endoprostheses]P Barragan, J Sainsous, M Silvestri, et al.
International Journal of Cardiology|April 1, 1993
Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre studyY Juillière, N Danchin, M E Bertrand, et al.
Circulation|May 23, 2001
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary interventionJ P Collet, G Montalescot, C Lesty, et al.
The New England Journal of Medicine|June 23, 2001
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarctionG Montalescot, P Barragan, O Wittenberg, et al.
International Journal of Cardiology|November 20, 2015
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO RegistryV Auffret, J Berland, P Barragan, et al.
Heart (British Cardiac Society)|February 7, 2009
Emergence of the concept of platelet reactivity monitoring of response to thienopyridinesL Bonello, A De Labriolle, M Scheinowitz, et al.
Heart (British Cardiac Society)|August 22, 2001
Randomised comparison of coronary stenting with and without balloon predilatation in selected patientsH Le Breton, J Boschat, P Commeau, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Rotablator and endoprosthesis on the left main coronary trunk]A F Chaix, P Barragan, M Silvestri, et al.
Journal of the American College of Cardiology|May 12, 2000
Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective proceduresM Silvestri, P Barragan, J Sainsous, et al.
Catheterization and Cardiovascular Diagnosis|December 31, 1997
Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patientsP Barragan, J Sainsous, M Silvestri, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1994
[Pilot study of the efficacy of ticlopidine in early patency of coronary endoprostheses]P Barragan, J Sainsous, M Silvestri, et al.
International Journal of Cardiology|April 1, 1993
Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre studyY Juillière, N Danchin, M E Bertrand, et al.
Circulation|May 23, 2001
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary interventionJ P Collet, G Montalescot, C Lesty, et al.
The New England Journal of Medicine|June 23, 2001
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarctionG Montalescot, P Barragan, O Wittenberg, et al.
International Journal of Cardiology|November 20, 2015
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO RegistryV Auffret, J Berland, P Barragan, et al.
Heart (British Cardiac Society)|February 7, 2009
Emergence of the concept of platelet reactivity monitoring of response to thienopyridinesL Bonello, A De Labriolle, M Scheinowitz, et al.
Heart (British Cardiac Society)|August 22, 2001
Randomised comparison of coronary stenting with and without balloon predilatation in selected patientsH Le Breton, J Boschat, P Commeau, et al.
Pageof 4